Strumento inattivo

Azioni Rennova Health Inc Nasdaq

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17/07/20
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29/06/20
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16/06/20

Dirigenti	Titolo	Età	Da
Darrell Peterson CEO	Chief Executive Officer	65	14/05/23
Gerard Dab CHM	Chairman	75	14/05/23
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Amministratori	Titolo	Età	Da
Gerard Dab CHM	Chairman	75	14/05/23
Sharon Hollis CEO	Chief Executive Officer	47	01/07/11
Francisco Roca BRD	Director/Board Member	58	14/05/23

Settore

	Variaz. 1 gen.	Capi.
SONIC HEALTHCARE LIMITED	-16,80%	8,79 Mrd
RADNET, INC.	+63,16%	4,19 Mrd
DR. LAL PATHLABS LIMITED	-4,03%	2,48 Mrd
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-43,01%	2,29 Mrd
NEOGENOMICS, INC.	-4,82%	1,97 Mrd
FLEURY S.A.	-18,74%	1,56 Mrd
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40,24%	1,22 Mrd
METROPOLIS HEALTHCARE LIMITED	+9,42%	1,13 Mrd
VIJAYA DIAGNOSTIC CENTRE LIMITED	+18,74%	933 Mln